If it involves metabolic dysfunction, then metabolic correction is therapeutically rational
Drucker DJ (2024) Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity
They control appetite and that is very often helpful, but theres no data to know how that interacts with some of the psychological components that go along with eating disorders. Slavin said that if the underlying emotional issues that caused the eating disorder are not addressed, then patients run into a whack-a-mole effect, where problem behaviors pop up in other areas
GLP-1 and dual agonist therapies benefit individuals with strong physiologic hunger, insulin resistance, or difficulty achieving satiety even after large meals
8 , eabm0756 (2022)
Research tells us that overweight or obese individuals might have impairments in dopaminergic pathways associated with reward sensitivity, leading to food noise: Eating decadent food prompts a dopamine surge, so you feel compelled to eat even when you arent hungry to get your fix. Satiety vs